Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Possible clinical effects of molecular hydrogen (H2) delivery during hemodialysis in chronic dialysis patients: Interim analysis in a 12 month observation

Fig 3

Changes in the defined daily dose of anti-hypertensive agents of the two groups at 12 months.

The distribution of changes in the Defined Daily Dose (DDD) of anti-hypertensive agents, categorized as increased, reduced and unchanged, was statistically analyzed using a chi-square test. *P<0.05 E-HD, electrolyzed water HD; C-HD, conventional HD.

Fig 3